Capacity Expansion
Balaji Amines Commissions India’s First Commercial DME Manufacturing Plant
NSE
balamines
BSE
530999
Balaji Amines Limited announced the successful commissioning of India’s first commercial-scale Dimethyl Ether (DME) manufacturing plant at its Solapur facility with a production capacity of 1,00,000 TPA. The company aims to strengthen its presence in alternative fuel and EV battery chemical segments.
PRICE-SENSITIVE TRIGGER
Event: .Commissioning of commercial DME manufacturing plant.
Type: Capacity Expansion
Impact: Positive
Immediate Effect: The development positions Balaji Amines as the only commercial-scale DME manufacturer in India and strengthens its diversification into clean fuel and EV battery chemical opportunities.
Key Metrics:
- DME Plant Capacity: 1,00,000 Metric Tonnes Per Annum (MTPA)
- DMC Installed Capacity: 15,000 MTPA
- DME Blending Limit with LPG (BIS Standard): Up to 8%
- Global LPG Blending Usage (International Markets): Up to 20%
- Service Focus: Alternative fuel and aerosol applications
Highlight Metric:
- Balaji Amines became the first company in India to commercially manufacture Dimethyl Ether (DME).
What Happened ?
Balaji Amines Limited informed stock exchanges that it has commenced commercial production of Dimethyl Ether (DME) at its Unit-IV facility located in Chincholi MIDC, Solapur, Maharashtra from May 20, 2026.
The company stated that DME is a clean alternative fuel that can be blended with LPG and has significant applications in aerosol and fuel industries. The plant has been established using advanced technology sourced from a foreign company.
Management also highlighted its broader strategy to become a major player in EV battery chemicals and new-age specialty chemicals.
Key Details
DME Plant Commissioning:
- Commercial production has started at Unit-IV in Solapur.
- The plant has annual production capacity of 1,00,000 MTPA.
- DME will be used as an alternate fuel and aerosol application chemical.
- Balaji Amines is currently the only commercial-scale DME manufacturer in India.
Product & Market Details:
- Product launched: Dimethyl Ether (DME).
- Product category: Bulk commodity chemical and LPG alternative fuel.
- Primary market focus is domestic.
- DME can be blended with LPG up to 8% under BIS standards.
Strategic Importance:
- DME is expected to reduce India’s dependence on LPG imports.
- The company sees strong long-term opportunity in clean fuel applications.
- Balaji Amines plans to cater to aerosol industry and commercial heating applications.
EV Battery Chemicals Opportunity:
- The company plans aggressive expansion into EV battery chemicals.
- DMC (Dimethyl Carbonate) is extensively used in EV battery electrolytes.
- Balaji Amines claims to be the sole manufacturer of electronic-grade DMC in India.
- NMP (N-Methyl Pyrrolidone) battery-grade solvents are also being developed for gigawatt-scale battery capacities.
Note:
- Management stated that some existing facilities may be repurposed for future EV battery chemical production.
Risk Analysis
Key Risks:
- Domestic DME adoption is still at an early stage.
- Regulatory approvals and industry standards are evolving.
- Commercial demand depends on LPG blending implementation by OMCs.
- Alternative fuel economics may fluctuate with energy prices.
Worst Case Scenario:
- If large-scale adoption of DME blending does not materialize, capacity utilisation and expected returns from the project may remain below expectations.
Risk Level: Medium
Company Commentary
- Management described the project as an important step toward India’s energy self-reliance.
- The company urged public sector oil marketing companies to accelerate DME blending adoption.
- Balaji Amines intends to evolve into a major player in EV battery chemicals.
- Management believes the company is positioned to become a leader in selected specialty chemical segments.
Official Exchange Filing: Balaji Amines Limited